AJU IB Investment Co., Ltd.
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed April 8, 2025), AJU IB Investment Co., Ltd. reported 8 stock positions worth $102.8 million. Its top holding was Arcellx (ACLX) at 78.2% of the portfolio, followed by Kymera Therapeutics (KYMR, 17.9%) and Seer (SEER, 1.8%).
- Most Recent 13F
- Q2 2026
- Location
- Seoul, M5
- CIK
- 0001710065
- Portfolio Value
- $102.8M (Q4 2024)
- SEC Filing
- 0001140361-25-012673 ↗ filed Apr 8, 2025
Holdings Value
Holdings 8 stocks · $102.8M
| ACLX Arcellx Inc. | 78.19% | 1,047,557 | $80.3M | — |
| KYMR Kymera Therapeutics Inc. | 17.89% | 457,059 | $18.4M | — |
| SEER Seer Inc. | 1.84% | 816,375 | $1.9M | — |
| RLYB Rallybio Corp. | 0.71% | 754,678 | $724K | — |
| XLO Xilio Therapeutics Inc. | 0.62% | 667,742 | $638K | — |
| STRO Sutro Biopharma Inc. Com SHS | 0.31% | 175,000 | $322K | — |
| CARM Carisma Therapeutics Inc. | 0.29% | 718,332 | $301K | — |
| RAPT THERAPEUTICS INC | 0.15% | 99,503 | $157K | — |
Portfolio Sells Q4 2024
No earlier filing to compare with.
Portfolio Buys Q4 2024
No earlier filing to compare with.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 0 | $0 | |
| Q1 2026 | 6 | $30.5M | ACLX, KYMR, SEER, RLYB, STRO |
| Q4 2025 | 7 | $22.8M | ACLX, RLYB, KYMR, SEER, XLO |
| Q3 2025 | 7 | $115.1M | ACLX, KYMR, SEER, XLO, RLYB |
| Q2 2025 | 8 | $91.9M | ACLX, KYMR, SEER, XLO, CARM |
| Q1 2025 | 8 | $84.0M | ACLX, KYMR, SEER, RLYB, XLO |
| Q4 2024 | 8 | $102.8M | ACLX, KYMR, SEER, RLYB, XLO |